124
Participants
Start Date
April 30, 2013
Primary Completion Date
March 31, 2015
Study Completion Date
May 31, 2015
GROUP A: Valsartan plus Chlorthalidone
Combination therapy of Valsartan plus Chlorthalidone: Valsartan 80 mg / Chlorthalidone 12,5 mg. Once daily during 12 weeks. If the goals of blood Pressure are uncontrolled at week 6, the dose will be increase to Valsartan 160 mg / Chlorthalidone 25 mg once daily.
GROUP B: Valsartan
GROUP B: Treatment monotherapy: Valsartan 80 mg once daily during 12 weeks. If the goals of blood Pressure are uncontrolled at week 6, the dose will be increase to Valsartan 160 mg once daily.
GROUP C: Chlorthalidone
GROUP C: Treatment monotherapy: Chlorthalidone 12,5 mg once daily during 12 weeks. If the goals of blood pressure are uncontrolled at week 6, the dose will be increase to Chlorthalidone 25 mg once daily.
MedPlus, Bogota DC
Centro de Diagnostico Cardiologico, Cartagena
Fundacion Cardiomet Cequin, Armenia
Centro AMCOR, Quito
Centro Clinico quirurgico, Quito
Centro médico de hipertensión arterial, Quito
Clínica DAME, Quito
Consultorio Edificio Novoa, Quito
Farma de Colombia SA
INDUSTRY